AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $638 | +77.2% | 273,679 | +81.0% | 0.00% | 0.0% |
Q2 2023 | $360 | +80.9% | 151,200 | +39.5% | 0.00% | – |
Q1 2023 | $199 | +126.1% | 108,400 | +134.1% | 0.00% | – |
Q4 2022 | $88 | -99.8% | 46,300 | +83.7% | 0.00% | – |
Q3 2022 | $54,000 | +50.0% | 25,200 | +96.9% | 0.00% | – |
Q2 2022 | $36,000 | -92.3% | 12,800 | -84.3% | 0.00% | -100.0% |
Q1 2021 | $467,000 | -35.5% | 81,588 | +0.8% | 0.00% | 0.0% |
Q4 2020 | $724,000 | +15.8% | 80,956 | +50.9% | 0.00% | 0.0% |
Q3 2020 | $625,000 | -46.2% | 53,656 | -25.9% | 0.00% | 0.0% |
Q2 2020 | $1,161,000 | +20.8% | 72,400 | -54.9% | 0.00% | 0.0% |
Q1 2020 | $961,000 | +79.0% | 160,496 | +294.3% | 0.00% | – |
Q4 2019 | $537,000 | -11.8% | 40,700 | -16.9% | 0.00% | -100.0% |
Q3 2019 | $609,000 | -58.0% | 49,000 | -45.6% | 0.00% | 0.0% |
Q2 2019 | $1,451,000 | – | 90,096 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |